Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in-vivo by Sarkar, Ankita et al.
University of Dayton 
eCommons 
Biology Faculty Publications Department of Biology 
7-2020 
Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling 
mitigate FUS mediated neurodegeneration in-vivo 
Ankita Sarkar 
Abijeet Singh Mehta 
Prajakta Deshpande 
Madhuri Kango-Singh 
Udai Bhan Pandey 
See next page for additional authors 
Follow this and additional works at: https://ecommons.udayton.edu/bio_fac_pub 
 Part of the Biology Commons, Biotechnology Commons, Cell Biology Commons, Genetics Commons, 
Microbiology Commons, and the Molecular Genetics Commons 
Author(s) 
Ankita Sarkar, Abijeet Singh Mehta, Prajakta Deshpande, Madhuri Kango-Singh, Udai Bhan Pandey, and 
Amit Singh (0000-0002-2962-2255) 




Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate
FUS mediated neurodegeneration in vivo
Neha Gogiaa, Ankita Sarkara, Abijeet Singh Mehta (Ph.D.)a, Nandini Rameshb,
Prajakta Deshpandea, Madhuri Kango-Singha,c,d, Udai Bhan Pandeyb, Amit Singha,c,d,e,f,⁎
a Department of Biology, University of Dayton, Dayton, OH 45469, USA
bDepartment of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, PA, USA
c Premedical Program, University of Dayton, Dayton, OH 45469, USA
d Center for Tissue Regeneration and Engineering at Dayton (TREND), University of Dayton, Dayton, OH 45469, USA
e The Integrative Science and Engineering Center, University of Dayton, Dayton, OH 45469, USA
f Center for Genomic Advocacy (TCGA), Indiana State University, Terre Haute, IN, USA
A R T I C L E I N F O
Keywords:
Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS)
Fused in Sarcoma (FUS)





A B S T R A C T
Amyotrophic Lateral Sclerosis (ALS), a late-onset neurodegenerative disorder characterized by the loss of motor
neurons in the central nervous system, has no known cure to-date. Disease causing mutations in human Fused in
Sarcoma (FUS) leads to aggressive and juvenile onset of ALS. FUS is a well-conserved protein across different
species, which plays a crucial role in regulating different aspects of RNA metabolism. Targeted misexpression of
FUS in Drosophila model recapitulates several interesting phenotypes relevant to ALS including cytoplasmic
mislocalization, defects at the neuromuscular junction and motor dysfunction. We screened for the genetic
modifiers of human FUS-mediated neurodegenerative phenotype using molecularly defined deficiencies. We
identified hippo (hpo), a component of the evolutionarily conserved Hippo growth regulatory pathway, as a
genetic modifier of FUS mediated neurodegeneration. Gain-of-function of hpo triggers cell death whereas its loss-
of-function promotes cell proliferation. Downregulation of the Hippo signaling pathway, using mutants of Hippo
signaling, exhibit rescue of FUS-mediated neurodegeneration in the Drosophila eye, as evident from reduction in
the number of TUNEL positive nuclei as well as rescue of axonal targeting from the retina to the brain. The Hippo
pathway activates c-Jun amino-terminal (NH2) Kinase (JNK) mediated cell death. We found that downregulation
of JNK signaling is sufficient to rescue FUS-mediated neurodegeneration in the Drosophila eye. Our study elu-
cidates that Hippo signaling and JNK signaling are activated in response to FUS accumulation to induce neu-
rodegeneration. These studies will shed light on the genetic mechanism involved in neurodegeneration observed
in ALS and other associated disorders.
1. Introduction
Amyotrophic Lateral Sclerosis (ALS), a fatal late-onset neurode-
generative disorder, is characterized by degeneration of motor neurons
in the brain and spinal cord (Brenner and Weishaupt, 2019; Riggs,
1985). One of the hallmarks of ALS is disruption in RNA metabolism,
which results in degeneration of motor neurons (Daigle et al., 2013;
Donnelly et al., 2013; Ling et al., 2013; Nussbacher et al., 2019; Ortega
et al., 2020). Mutations in more than 30 genes including superoxide
dismutase1 (SOD1)(Rosen et al., 1993), TAR DNA-binding protein-43
(TDP-43)(Kabashi et al., 2008; Rutherford et al., 2008), C9ORF72
(DeJesus-Hernandez et al., 2011; Renton et al., 2011), ubiquilin-2
(UBQLN2) (Deng et al., 2011), optineurin (OPTN)(Maruyama et al.,
2010), and fused in sarcoma (FUS)(Kwiatkowski et al., 2009; Vance
et al., 2009) results in ALS (White and Sreedharan, 2016). Of these, FUS
is not only involved in causing ALS associated neurodegeneration (Chen
et al., 2011), but also serves as a factor in the pathogenesis of other
neurodegenerative disorders like polyglutamine diseases (Doi et al.,
2008; Kino et al., 2016). FUS is a DNA/RNA binding protein that plays
crucial role(s) in mRNA metabolism, nucleocytoplasmic RNA transport,
and translation (Coyne et al., 2017; Kwiatkowski et al., 2009; Yang
et al., 1998; Zinszner et al., 1997). Normally FUS shuttles between the
nucleus and cytoplasm. Pathogenic mutations in FUS result in cyto-
plasmic mislocalization of a small fraction of the FUS protein. It sug-
gests that cytoplasmic retention of FUS is likely causing cytotoxicity
(Lanson Jr et al., 2011; Zinszner et al., 1997). Further, deletion of
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Nuclear Export Signal (NES) disrupts the ability of this protein to enter
the cytoplasm, which likely results in ALS neuropathy (Lanson Jr et al.,
2011). The RNA-binding ability of FUS has been suggested to play a
major role in FUS mediated neurodegeneration and has been demon-
strated by generating mutations in RNA recognition motifs (RRM) like
R518K and R521C However, the exact mechanism(s) that can block
FUS-mediated neurodegeneration is unclear. Therefore, it is important
to understand functional consequences of disease-causing mutations in
FUS, which promote cytoplasmic accumulation of mutant FUS, in order
to discern the mechanism of FUS-mediated neurodegeneration.
Since the genetic machinery is highly conserved, several animal
models including mice, zebrafish, and fruit flies are in use to study the
molecular mechanisms of ALS disease (Casci and Pandey, 2015; Pandey
and Nichols, 2011; Picher-Martel et al., 2016). Amongst these, Droso-
phila melanogaster a.k.a. fruit fly, serves as a highly versatile and ge-
netically tractable human disease model (McGurk et al., 2015;
Olesnicky and Wright, 2018; Pandey and Nichols, 2011; Sarkar et al.,
2016; Singh and Irvine, 2012; Yeates et al., 2019). The Drosophila eye
serves as a useful model to study neurodegenerative disorders like ALS
(Casci and Pandey, 2015) as the retinal neurons are sensitive to cellular
insult(s) and are not crucial for the survival and reproductive ability of
the fly (Sarkar et al., 2016; Tare et al., 2011). The adult compound eye
of Drosophila develops from an epithelial bi-layer structure, which is
housed inside the larva, called an eye-antennal imaginal disc. The larval
eye imaginal disc develops into the adult compound eye comprised of
800 unit eyes called ommatidia (Kumar, 2018; Ready et al., 1976; Singh
et al., 2005; Singh et al., 2012; Tare et al., 2013). Misexpression of wild-
type FUS or mutant FUS, in the differentiating retinal neurons of Dro-
sophila eye, using a GMR-Gal4 driver (Moses and Rubin, 1991) results in
severe degeneration of retinal neurons. Targeted misexpression of FUS
(FUS) or mutant FUS in motor neurons exhibits locomotor dysfunction
(Casci and Pandey, 2015; Coyne et al., 2017; Daigle et al., 2013; Lanson
Jr et al., 2011; Pandey and Nichols, 2011; Xia et al., 2012).
We have used a well-characterized fruit fly model to screen for the
genetic modifiers of FUS-mediated neurodegeneration using molecu-
larly defined deletions. We identified a deficiency, which uncovers
hippo (hpo) and other genes as a suppressor of FUS-mediated neurode-
generation. The Hippo pathway is an evolutionarily conserved growth
regulatory pathway (Kango-Singh and Singh, 2009; Ma et al., 2019).
The core components of the Hippo pathway are Ste20 family protein
kinase hpo (Harvey et al., 2003; Pantalacci et al., 2003; Udan et al.,
2003; Wu et al., 2003), the nuclear Dbf-2- related (NDR)-family kinase-
warts (wts)(Justice et al., 1995; Xu et al., 1995), and yorkie (yki)- the
Drosophila orthologs of the mammalian transcription co-activator yes-
associated protein (YAP) (Huang et al., 2005). When Hippo pathway is
activated, Hpo binds with and phosphorylates Salvador (Sav), a protein
containing WW and coiled-coil domains, and phosphorylates the
downstream Wts kinase (Kango-Singh et al., 2002; Kango-Singh and
Singh, 2009; Tapon et al., 2002). The active, phosphorylated form of
Wts binds with an adaptor protein Mob-as-tumor suppressor (Mats) (Lai
et al., 2005) and in turn phosphorylates the transcriptional co-activator
Yki. The phosphorylated form of Yki binds with 14–3-3 proteins, and
undergoes 14–3-3 mediated proteasomal degradation in the cytoplasm
(Dong et al., 2007; Ren et al., 2010; Wei et al., 2007). However,
downregulation of the Hippo signaling leads to release of Wts-mediated
repression of Yki, and the unphosphorylated Yki goes into the nucleus,
binds to its partner(s) such as the TEAD family transcription factor
Scalloped (Sd), and regulates expression of the downstream targets of
the Hippo pathway like expanded (ex), drosophila inhibitor of apoptosis
(diap1), cyclins, bantam (ban), etc. (Fulford et al., 2018; Kango-Singh
and Singh, 2009; Yu and Guan, 2013). Loss-of-function of hpo, sav, wts,
mats or overexpression of yki activity leads to cell proliferation and over
growth, while gain-of-function of the Hpo signaling leads to apoptosis
or cell death (Kango-Singh and Singh, 2009).
The Hippo pathway activates JNK, an evolutionarily conserved
signaling pathway, to trigger cell death (Ma et al., 2015; Ma et al.,
2017). JNK signaling is involved in a wide array of signaling events
underlying tumorigenesis and is known to regulate cell proliferation,
invasive migration, and cell death (Dhanasekaran and Reddy, 2017).
JNK, or stress activated kinase proteins of mitogen-activated protein
kinase (MAPK) superfamily (Adachi-Yamada et al., 1999; Adachi-
Yamada and O'Connor, 2002), induce cell death due to phosphorylation
of transcription factors involved in cell death (Dhanasekaran and
Reddy, 2008). JNK signaling pathway in Drosophila gets activated
downstream of the Tumor Necrosis Factor (TNF) homolog Eiger (Egr)
and its receptor Wengen (Wgn) by a conserved downstream signaling
cascade. The core components of this pathway comprises of Tak1 (TGF-
β- activating kinase 1); JNK Kinase Kinase (JNKKK), Hemipterous (Hep;
JNK Kinase- JNKK, which is closely related to mitogen-activated pro-
tein Kinase Kinases (MAPKKs) (Glise et al., 1995; Tournier et al., 1997).
Other components are Basket (Bsk; a Jun kinase), D-Jun (Jun), and
Puckered (Puc). bsk acts downstream of hep and is activated by con-
stitutive hep phosphorylation (Sluss et al., 1996). Phosphorylation of
Jun leads to activation of the JNK signaling pathway that functions as a
dual specificity protein phosphatase (Martín-Blanco et al., 1998). puc
functions as a transcriptional target of JNK signaling and is known to
regulate JNK signaling through a negative feedback loop (Adachi-
Yamada et al., 1999; Adachi-Yamada and O'Connor, 2002). Further-
more, ectopic activation of JNK signaling induces cell death during
early eye imaginal disc development (Singh et al., 2006). Here we
present evidences to show that targeted misexpression of FUS triggers
neurodegeneration as seen in ALS models by activating the Hippo sig-
naling pathway, which we identified in a forward genetic screen. We
further investigated the genetic mechanism and found that activation of
the Hippo signaling pathway due to gain-of-function of FUS in turn
triggers the JNK signaling to induce neurodegeneration in the devel-
oping Drosophila eye.
2. Materials and method
2.1. Fly stocks
The fly stocks used in this study are listed in FlyBase (http://flybase.
bio.indiana.edu). We used the transgenic fly strains that carry full
length FUS (UAS-FUS)(Lanson Jr et al., 2011) and mutant FUS, UAS-
FUS R518K and UAS-FUS R521C(Casci et al., 2019). Other stocks used
are UAS-hpo (Udan et al., 2003), yw, hsflp; UAS-hpoRNAisymp19/SM6-
TM6B,Tb (Pantalacci et al., 2003), UAS-wts13f (Kwon et al., 2015), UAS-
wtsRNAi (Fernández et al., 2011; Rauskolb et al., 2011), UAS-ykiRNAi (N
+C) (Zhang et al., 2008), a hyperactivated form that allows yki activa-
tion, UAS-yki3SA (Oh and Irvine, 2008), UAS-Djunaspv7(Treier et al.,
1995), UAS-bskDN (Adachi-Yamada et al., 1999), UAS-hepAct (Glise
et al., 1995), UAS-puc (Martín-Blanco et al., 1998) and diap1–4.3-GFP
(Ren et al., 2010). The diap1–4.3- GFP gene, contains a 4.3-kb diap1
genomic fragment from +1.37 kb to +5.68 kb, which contains a Hippo
response element that drives the Diap1 expression in response to Hippo
pathway activity where GFP is a reporter for Yki activity. We used a
molecularly defined deficiency Df(2R)BSC782/+, which is located on
the right arm of the second chromosome, and uncovers βTub56D, par-1,
CG16926, CG7744, CG15120, mei-W68, oseg6, TBCB, rep and hpo genes
(listed in FlyBase). We used the Canton-S (Wild-type) stock of D. mel-
anogaster in this study. Fly stocks used in this study (Supplementary
Table 1) were maintained at 25 °C on cornmeal, molasses food.
2.2. Genetic crosses
We employed the Gal4/UAS system for targeted misexpression
studies (Brand and Perrimon, 1993). The GMR-Gal4 enhancer directs
expression of transgenes in the differentiating retinal precursor cells in
the developing larval eye-antennal imaginal discs (Moses and Rubin,
1991; Tare et al., 2011). We used GMR-Gal4 to drive expression of
transgenes. We used GMR-Gal4/ CyO; UAS-FUS / TM3 Sb e Ser
N. Gogia, et al. Neurobiology of Disease 140 (2020) 104837
2
(GMR > FUS), GMR-Gal4/ CyO; UAS-FUS R518K / TM3 Sb e Ser
(GMR > FUS R518K), GMR-Gal4/ CyO; UAS-FUS R521K/ TM3Sb e Ser
(GMR > FUSR521K) to sample FUS-mediated neurodegeneration in the
eye. All fly stocks were maintained at 25 °C. All Gal4/UAS crosses were
maintained at 18 °C, 25 °C, or 29 °C to sample different induction levels
(Singh and Choi, 2003). The third instar larval eye-antennal imaginal
discs were used for immunohistochemistry purposes.
2.3. Immunohistochemistry
The eye-antennal imaginal discs were dissected from the wandering
third-instar Drosophila larvae in 1× PBS (Phosphate Buffered Saline,
pH 7.4) following the standard protocol (Sarkar, 2018; Singh et al.,
2002). Tissue samples were then fixed in 4% paraformaldehyde for
20 min and washed with 1× PBST (1XPBS + 0.2%TritonX-100), 3
times for 10 min each. Tissues were incubated with different combi-
nations of primary and secondary antibodies. The primary antibodies
used were: rabbit anti-FUS (1:500, Bethyl Laboratories, A300-302A),
mouse anti-Dlg (1:100, Developmental Studies Hybridoma Bank-DSHB,
4F3), mouse anti-Wg (1:50, DSHB, 4D4), rat anti-Elav (1:100; DSHB,
7E8A10), mouse anti-Chaoptin, MAb24B10 (1:100, DSHB, 24B10)
(Zipursky et al., 1984), and rabbit anti-β-galactosidase (1:100, Pro-
mega, Z3781). Secondary antibodies (Jackson Immuno Research) used
were donkey anti-rabbit IgG conjugated with FITC (dilution 1:200),
donkey anti-mouse IgG conjugated with Cy3 (dilution 1:250), and goat
anti-rat IgG conjugated with Cy5 (dilution 1:250). After primary and
secondary antibody incubation, tissue samples were washed with
1XPBST (X3) for 10 min each to remove excess antibody bound to
sample. Following washing, tissue samples were mounted in Vecta-
shield mountant (Vector laboratories-H1000). The images were
scanned using Olympus Fluoview-3000 Laser Scanning Confocal Mi-
croscope (LSCM) (Singh and Gopinathan, 1998), and final figures were
made using Adobe Photoshop CS6 software (Sarkar, 2018). The quan-
tification of GFP intensity was done using built-in program in Olympus
Fluoview 3000 confocal microscope. The statistical analysis of eye-an-
tennal imaginal discs images was conducted using Microsoft Excel 2017
software. p-values were calculated using a Student's two-tailed t-test
and the error bars represent the values of standard deviation calculated
from the mean (Tare et al., 2016).
2.4. Detection of cell death
The TUNEL assay marks the cells undergoing cell death. In TUNEL
staining, the cleavage of double and single-stranded DNA is labeled by a
Fluorescent tag (TMR Red) (McCall and Peterson, 2004; White et al.,
1994). The fluorescently labeled nucleotides are added to 3’ OH ends in
a template-independent manner by Terminal Deoxynucleotidyl trans-
ferase (TdT). The dying cell's fragmented DNA is tagged with a fluor-
ochrome and can be detected using a fluorescence microscope or con-
focal microscope. Eye antennal discs after secondary antibody staining
(Singh et al., 2006) were blocked in 10% normal donkey serum in
Phosphate buffered saline with 0.2% Triton X-100 (PBT) and labeled for
TUNEL assays using a cell death detection kit from Roche Diagnostics
(12156792910). For negative controls, eye-antennal imaginal discs
were treated with a cell death detection labeling mix without the TdT
enzyme added.
The TUNEL positive nuclei were counted from five sets of eye
imaginal discs for each experiment. The cell count number was used for
statistical analysis using Microsoft excel 2013. The p-values were cal-
culated using a Student's two-tailed t-test. The error bars represent the
standard deviation from the mean (Steffensmeier et al., 2013).
2.5. Adult eye imaging
The adult flies were prepared for imaging by freezing them at
−20 °C for approximately 2 h. Following this incubation, the flies were
mounted on a dissection needle. The needle carrying the fly was placed
horizontally over a glass slide using a putty. Images were captured on a
MrC5 colour camera mounted on an Axioimager.Z1 Zeiss Apotome
using a Z-sectioning method (Sarkar, 2018; Wittkorn et al., 2015). The
final images were generated by compiling individual stacks from the Z-
section using the extended depth of focus function of Axiovision soft-
ware version 4.6.3.
2.6. Scanning electron microscopy (SEM)
SEM was carried out using the standard protocol (Tare and Singh,
2009). The flies with phenotype were dehydrated through a series of
increasing concentrations of acetone. The dehydrated fly samples were
then incubated in 1:1 ratio of acetone and Hexamethyldisilazane
(HMDS, Electron Microscopy Sciences) solution for 24 h, followed by
incubation in 100% HMDS alone. The flies were then air dried in the
fume hood. The samples were mounted onto the conductive carbon tape
attached to stubs (Electron Microscopy Sciences). The flies mounted on
the stub were then subjected to sputter coating with gold using a
Denton vacuum sputter coater (DV502). The samples were photo-
graphed using a Hitachi S-4800 High Resolution Scanning Electron
Microscope (HRSEM) Singh et al. (2019). The images were later ana-
lyzed using Adobe Photoshop CS6 software.
2.7. Western blot
The protein samples were extracted from heads of Wild-type,
GMR > FUS, GMR > FUS- R518K, and GMR > FUS-R521C adult flies
using a standardized protocol (Gogia et al., 2017). The primary anti-
bodies used were Phospho-SAPK/JNK (Thr183/Tyr185) (81E11)
(1:3000, Cell Signaling) and anti-FUS (1:1500, A300-302A, Bethyl la-
boratories). A signal was detected using a Horse Radish Peroxidase
(HRP) conjugated goat anti-rabbit IgG (1:5000), and Super Signal West
Dura Extended Duration Substrate (Thermo Scientific). Images were
captured using the BioSpectrum® 500 imaging system and analyzed
using Adobe Photoshop CS6 software. To measure the band intensity,
statistical analysis was conducted on western blots using Microsoft
Excel 2017 software. The p-values were calculated using Student's two-
tailed t-test and the error bars represent the values of standard devia-
tion calculated from the mean (Sarkar et al., 2018).
HEK293T cells (ATCC® CRL-3216™) were cultured in Advanced
DMEM supplemented with 10% FBS and 1% Glutamax and grown at
37 °C and 5% CO2 (Casci et al., 2019). HEK293T cells were transiently
transfected using Turbofect (Invitrogen) with pCI-neoHA-FUS WT, pCI-
neoHA-FUS R518K and pCI-neoHA-FUS R521C. Cells were lysed in
RIPA buffer (150 mM NaCl, 1% NP40, 0.1% SDS, 1% sodium deox-
ycholate, 50 mM NaF, 2 mM EDTA, 1 mM DTT, 2.5 mM Na orthova-
nadate, 1× protease inhibitor cocktail [Roche 11836170001), pH 7.4]
24 h post-transfection, and centrifuged down at 12000 ×g for 10 min.
The supernatant was boiled in 1× NuPage LDS-Sample buffer (In-
vitrogen NP0007) at 95 °C for 5 min. SDS-PAGE was performed using
4–12% NuPage Bis-Tris gels (Invitrogen), and the separated proteins
were transferred onto nitrocellulose membranes using the iBlot2 system
(Life Technologies 13120134). Nitrocellulose membranes were in-
cubated overnight at 4 °C with primary antibody (1:1000 LATS1, SCBT
#398560; 1:500 Phospho-LATS1 (Thr1079), CST #8654; 1:8000 α-tu-
bulin, Sigma T5168) followed by secondary antibody at room tem-
perature for 1 h. Membranes were imaged on Odyssey CLx (LI-COR
Biosciences) and quantification of bands was performed using Image
Studio (LI-COR Biosciences). Statistical analysis was performed using
Graphpad Prism.
2.8. Real time quantitative polymerase chain reaction
Real time Quantitative Polymerase Chain Reaction (RT-qPCR) was
performed according to the standardized protocol (Mehta and Singh,
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2017; Mehta et al., 2019). Total RNA was extracted in 500 μl of TRIzol
Reagent (Thermo Fisher, Cat. No. # 15596926) from twenty pairs of
third instar eye-antennal imaginal discs (n = 40), which were dissected
from wild-type (WT), GMR > FUS, GMR > FUS-R518K and
GMR > FUS-R521C background larvae. The quality of isolated RNA
was determined by using the Nanodrop 2000 spectrophotometer
(Thermo Scientific). Good quality samples had A260/A280 ratio greater
than 2 and a peak at 260 nm. cDNA was produced from total RNA
through RT-PCR using the first- strand cDNA synthesis kit (GE health-
care, Cat# 27926101). RT-qPCR was performed using iQ™ SYBR Green
Supermix (Bio-Rad) and Bio- Rad iCycler (Bio-Rad) following the kits
protocol for 25 μl. Primers used for Jun-N-terminal kinase (JNK) are:
(fwd: CCAACCGTCCGAAACTATGT); rev: CCGGCGGCTATTCTGATTA
TTA). The expression level of Glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) was used as an internal control to normalize the
results (fwd: CAATGGATTTGGTCGCATCG; rev: CCGTTGACCACCAGG
AAACC). The fold change was calculated relative to the expression level
of the respective control (WT, Canton-S).
3. Results
3.1. Search for genetic modifier of human-FUS mediated neurodegeneration
The larval eye imaginal discs develop into an adult compound eye
comprised of nearly 800 ommatidia arranged in a stereotypical fashion
(Fig. 1 A, F). We stained the eye-antennal imaginal discs with Disc large
(Dlg: Green, a membrane specific marker) and pan neural marker Em-
bryonic Lethal Abnormal Vision (Elav: Red), which marks the nuclei of
the photoreceptor neurons (Fig. 1A). Targeted misexpression of full
length human-FUS (FUS) in differentiating retinal neurons using a Glass
Multiple Repeat (GMR) eye specific promoter (GMR-Gal4/+), exhibits
a strong retinal degeneration phenotype in the eye imaginal disc
(n = 10, Fig. 1C) and highly reduced adult eye with loss of eye pig-
mentation (n = 200, Fig. S1A, Fig. 1H). The control GMR-Gal4 driver
alone does not show any neurodegenerative phenotype as seen in the
eye imaginal disc and the adult eye (Fig. 1B, G, S1A). We tested other
transgenic alleles of mutant FUS as well. Targeted misexpression of FUS
R518K (Fig. 1D, I), and FUS R521C (Fig. 1E, J) also exhibits strong
neurodegenerative phenotypes both in eye imaginal discs and the adult
eye (Fig. S1A).
We verified if these transgenes were expressing human FUS protein
(GMR > FUS, in heterozygous combination) in the Drosophila eye by
using an antibody against human FUS protein. We found that FUS ex-
pression was restricted to the GMR expression domain of the developing
third instar eye imaginal disc of GMR > FUS, GMR > FUS R518K, and
GMR > FUS R521C (Fig. S2AeC, G). These results confirmed that the
neurodegeneration seen in the eye-antennal imaginal discs and the
adult fly eyes is due to misexpression of the human FUS protein. We
also calculated the intensity of FUS signals as seen by im-
munohistochemistry detected by FUS antibody in eye-antennal ima-
ginal disc and found that there was no significant difference of FUS
levels in all three alleles (Fig. 1G). The protein extracts from these
samples showed a significant accumulation of FUS protein in a semi-
quantitative western blot (Fig. S2 H, H').
In order to understand the genetic basis of the FUS gain-of-function
mediated neurodegeneration as seen in ALS, we employed a forward
genetic screen using the molecularly defined deficiencies. We identified
a deficiency line Df(2R)BSC782, which in heterozygous combination
(Df(2R)BSC782/+) can rescue the GMR > FUS mediated neurode-
generation as seen in the eye imaginal disc and the adult eye (Fig. 1N,
S). This molecularly defined Df(2R)BSC782/+ deficiency is located on
the right arm of the second chromosome, and uncovers βTub56D, par-1,
CG16926, CG7744, CG15120, mei-W68, oseg6, TBCB, rep, and hpo genes
(Fig. 1K). Targeted misexpression of other FUS transgenes in Df(2R)
BSC782/+ background, which includes GMR > FUS R518K + Df(2R)
BSC782/+ (Fig. 1O, T) and GMR > FUS R521C + Df(2R)BSC782/+
(Fig. 1P, U), exhibit a stronger rescue with a near complete wild-type
phenotype in both the eye-antennal imaginal discs as well as the adult
eyes. The heterozygous combination of deficiency Df(2R)BSC782/+
alone (Fig. 1L, Q) and GMR > Df(2R)BSC782/+ (Fig. 1M, R) respec-
tively, which served as controls, exhibit a wild-type phenotype in the
eye-antennal imaginal disc and the adult eye. We also tested the levels
of FUS expression levels in eye-imaginal discs from GMR > FUS, Df(2R)
BSC782/+, GMR > FUS R518K + Df(2R)BSC782/+ and GMR > FUS
R521C + Df(2R)BSC782/+, where FUS-mediated neurodegenerative
phenotypes are rescued (Fig. 1). Interestingly, in this background, FUS
levels were not significantly affected (Fig.S2D-G).
3.2. hpo acts as a genetic modifier of FUS mediated neurodegeneration
To narrow down the gene, which is responsible for modifying the
FUS mediated neurodegeneration phenotype, we individually tested the
genes uncovered by Df(2R)BSC782 deficiency (Fig. 1K), using gain-of-
function and loss-of-function approaches. Of these, modulation of hippo
(hpo), one of the genetic loci uncovered by Df(2R)BSC782, affects the
FUS neurodegenerative phenotype (Fig. 2). In comparison to the wild-
type adult eye (Fig. 2A), and control GMR-Gal4/+ eye (Fig. 2B), gain-
of-function of FUS as seen in GMR > FUS/+ (Fig. 1H, 2C), GMR > FUS
R518K/+ (Fig. 1I, 2D), and GMR > FUS R521C/+ (Fig. 1J, 2E) results
in a strong neurodegenerative phenotype (Lanson et al., 2011). These
eyes are of reduced size and exhibit a rough eye phenotype, with dis-
organized lenses that clearly marks the onset of neurodegeneration.
Gain-of-function of hpo in various backgrounds like FUS
(GMR > FUS + hpo) (Fig. 2F), FUS R518K (GMR > FUSR518K + hpo;
Fig. 2G), and FUS R521C (GMR > FUS R521C + hpo; Fig. 2H) exhibit
further enhancement in the severity of neurodegenerative phenotypes
of FUS gain-of-function in the eye. On the contrary, loss-of-function of
hpo by misexpressing hpoRNAi, with FUS (GMR > FUS + hpoRNAi), FUS
R518K (GMR > FUS R518K + hpoRNAi), or FUS 521C (GMR > FUS
R521C + hpoRNAi), rescues FUS mediated neurodegenerative phenotype
(Fig. 2 I, J, K). These phenotypes were statistically significant (Fig.
S1B). Our data strongly suggests that the hpo gene plays a role in
triggering FUS mediated neurodegeneration in the Drosophila eye.
3.3. Hippo signaling downregulation can rescue FUS mediated
neurodegeneration
Hpo, a kinase, is one of the core components of an evolutionarily
conserved Hippo signaling pathway. We therefore tested if this neuro-
protective function is exclusive to hpo gene or if it is dependent on the
Hippo signaling pathway. We therefore tested other members of the
Hippo signaling pathway. Ectopic expression of FUS, FUS R518K, and
FUS R521C in differentiating retinal neurons using a GMR driver, which
results in a neurodegenerative phenotype in the eye-antennal imaginal
discs (Fig. 1) and the adult fly eye (Fig. 1, 2C, D, E). In comparison to
the controls (Fig. 3A, B), activation of Hippo signaling via misexpres-
sion of wts and ykiRNAi along with FUS (GMR > FUS + wts,
GMR > FUS + ykiRNAi), results in a strong enhancement of neurode-
generative phenotypes (Fig. 3F, I) as compared to the controls (Fig. 3A,
B, C). Similarly, activation of Hippo signaling in the gain-of-function of
FUS R518K (GMR > FUS R518K + wts, Fig. 3G; GMR > FUS
R518K + ykiRNAi, Fig. 3J), or FUS R521C (GMR > FUS R521C + wts,
Fig. 3H; and GMR > FUS R521C + ykiRNAi, Fig. 3K) backgrounds in the
GMR domain of eye worsens the FUS mediated neurodegeneration
phenotype (Fig. 3C, D, E).
We further verified our hypothesis by downregulation of Hippo
signaling using wts RNAi and yki misexpression in the FUS gain-of-
function backgrounds. Downregulation of Hippo signaling in FUS
(GMR > FUS + wtsRNAi, Fig. 3L GMR > FUS + yki3SA, Fig. 3O), FUS
R518K (GMR > FUS R518K + wtsRNAi, Fig. 3M; GMR > FUS
R518K + yki3SA, Fig. 3P), or FUS R521C (GMR > FUS
R521C + wtsRNAi, Fig. 3N; and GMR > FUS R521C + yki3SA, Fig. 3Q)
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Fig. 1. Identification of a molecularly defined deletion as a genetic modifier of human FUS mediated neurodegeneration.
Eye imaginal disc and the adult eye of (A, F) Wild-type and (B, G) GMR-Gal4/+ (an eye specific promoter) that serve as control. (A)Third instar larval eye antennal
imaginal disc, which develop into (F) the adult compound eye. Note that the eye-antennal imaginal discs are stained with a membrane specific marker Disc large (Dlg:
Green) and pan neural marker Embryonic Lethal Abnormal Vision (Elav: Red), which marks the nuclei of the photoreceptor neurons. In comparison to controls,
misexpression of (C, H) FUS (GMR-Gal4/CyO; UAS-FUS/ TM3Sb e Ser, GMR > FUS) or mutant FUS (D, I) FUS R518K (Gal4/CyO; UAS-FUS R518K/ TM3Sb e Ser,
GMR > FUS R518K), and (E, J) FUS R521C (Gal4/CyO; UAS-FUS R5521C/ TM3Sb e Ser, GMR > FUS R521C) in differentiating retinal neurons using GMR-Gal4
driver results in strong neurodegeneration in retinal neurons as seen in (C, D, E) eye imaginal discs and the (H, I, J) adult eye. Note that phenotype worsens as the (C,
D, E) larval eye-antennal imaginal discs transforms into (H, I, J) adult eyes. In a deficiency screen, Df(2R)BSC782 was identified as a genetic modifier of FUS
mediated neurodegenerative phenotype. (K) The map shows the region and genes (including hpo) covered by deficiency line (Df(2R)BSC782/+). (L, Q) Df(2R)
BSC782/+ (M, R) GMR > Df(2R)BSC782/+ served as controls. In a heterozygous background of (Df(2R)BSC782/+), misexpression of (N, S) FUS (GMR > FUS/
+;Df(2R)BSC782/+), or mutant FUS, (O, T) FUS R518K (GMR > FUS R518K/+; Df(2R)BSC782/+) and (P, U) FUS R521C (GMR > FUS R521C/+; Df(2R)BSC782/
+), results in the significant rescue of FUS mediated neurodegeneration as seen in (N, O, P) the eye-antennal imaginal discs and (S, T, U) the adult compound eyes of
Drosophila respectively. The neurodegeneration phenotype in the eye was significantly rescued and pigment cells were restored. The orientation of all imaginal discs
in the figure is posterior to left and dorsal up. Magnification of all eye discs is 20X. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
Fig. 2. hpo is the genetic modifier of FUS mediated
neurodegeneration in Drosophila eye.
(A) Wild-type and (B) GMR-Gal4/+ adult fly eyes
serve as controls. Targeted misexpression of FUS or
mutant FUS R518K and FUS R521C in the GMR do-
main of eye (C) GMR > FUS (D) GMR > FUS R518K
(E) GMR > FUS R521C results in reduced and rough
eye phenotype due to neurodegeneration. Activation
of Hippo signaling by misexpressing hpo along with
FUS or mutant FUS (FUS R518K and FUS R521C) in
the GMR domain of eye using GMR driver, (F)
GMR > FUS + hpo, (G) GMR > FUS R518K+ hpo,
(H) GMR > FUS R521C + hpo, further enhances the
FUS mediated neurodegeneration phenotype as
compared to misexpressing FUS or mutant FUS in
GMR domain alone. Downregulation of Hippo sig-
naling by misexpressing hpoRNAi along with FUS (I)
GMR > FUS+ hpoRNAi, or mutant FUS (J)
GMR > FUS R518K+ hpoRNAi, (K) GMR > FUS
R521C + hpoRNAi in the GMR domain rescues the
FUS mediated neurodegeneration, as seen in SEM
images of the adult eyes of FUS or mutant FUS in
GMR domain alone. Note that all transgenes are in
heterozygous combination. Magnification of all the
scanning electron microscopic images of adult fly
eyes is 180X.,
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Fig. 3. Downregulation of Hippo signaling rescues FUS medi-
ated neurodegeneration. (A) Wild-type and (B) GMR-Gal4/+
adult fly eyes as controls. Targeted misexpression of WT FUS or
mutant FUS R518K and FUS R521C in the GMR domain of eye
(C) GMR > FUS (D) GMR > FUS R518K (E) GMR > FUS R521C
results in rough eye or neurodegeneration phenotype.
Activation of Hippo signaling by misexpressing wts or ykiRNAi
along with full length wild-type FUS or mutant FUS (FUS R518K
and FUS R521C) in the GMR domain of eye using GMR driver,
(F) GMR > FUS + wts, (G) GMR > FUS R518K + wts, (H)
GMR > FUS R521C + wts, (I) GMR > FUS + ykiRNAi, (J)
GMR > FUS R518K + ykiRNAi, (K) GMR > FUS
R521C + ykiRNAi, further enhances or worsens the FUS or mu-
tant FUS alone mediated neurodegeneration phenotype. In-ac-
tivation of Hippo signaling by misexpressing wtsRNAi, yki3SA
along with full length wild-type FUS (L) GMR > FUS + wtsRNAi,
(O) GMR > FUS + yki3SA, or mutant FUS (M) GMR > FUS
R518K + wtsRNAi, (N) GMR > FUS R521C + wtsRNAi, (P)
GMR > FUS R518K + yki3SA, (Q) GMR > FUS R521C + yki3SA
in GMR domain rescues the FUS mediated neurodegeneration,
as seen in scanning electron microscopic (SEM) images of adult
fly eyes of FUS alone or mutant FUS. Note that all transgenes are
in heterozygous combination. Magnification of all the SEM
images of the adult fly eyes is 180X.
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results in overgrowth and in the case of wts showed rescue of the
neurodegenerative phenotype. These phenotypes were statistically
significant (Fig.S2C).
3.4. Downregulation of Hippo signaling can block FUS mediated neuronal
cell death
We decided to test if Hippo signaling downregulation rescues FUS
mediated neurodegeneration by blocking cell death. We used TUNEL
staining, which marks the fragmented DNA, to mark the nuclei of the
dying neurons (Cutler et al., 2015; Gogia et al., 2017; McCall and
Peterson, 2004; Sarkar, 2018; Tare et al., 2011; White et al., 1994). We
performed TUNEL staining in third instar larval eye-antennal imaginal
discs of the wild-type larvae (Fig. 4A), GMR > FUS (Fig. 4B). The
number of TUNEL positive cells, shown as white dots, were quantified
from five eye-antennal imaginal discs (n = 5) of each genotype. We
took the mean, standard deviation, standard error, and p-values of this
data and recorded it on a graph (Fig. 4I). Note that there are fewer
Fig. 4. Downregulation of Hippo signaling blocks cell death in the differentiating neurons to rescue FUS mediated neurodegeneration. TUNEL, marks the fragmented
DNA within the nuclei of dying cells (also called as TUNEL positive cells). TUNEL staining was carried out in (A) wild-type third instar larval eye-antennal imaginal
disc, displaying randomly distributed TUNEL positive dying cells shown as white dots. The area between the white dotted line and posterior margin of the eye
imaginal disc is the domain of GMR-Gal4 driver. The number of TUNEL positive cells were counted from five eye-antennal imaginal discs (n = 5) of all the genotypes
in the GMR-Gal4 domain. (B) Misexpression of FUS in the differentiating photoreceptor neurons of the eye using GMR-Gal4, eye specific promoter (GMR > FUS),
show elevated levels of TUNEL positive cells, indicating increased frequency of cell death in photoreceptor neurons, as compared to the wild-type control (A,I). Note
that the number of dying cells (TUNEL positive cells) increase nearly ~0.5 fold in (B) GMR > FUS as compared to the (A) wild-type eye-antennal imaginal discs.
Activation of Hippo signaling by misexpressing hpo, wts, ykiRNAi in WT FUS background, in GMR domain of eye in (C) GMR > FUS + hpo, (E) GMR > FUS + wts, and
(G) GMR > FUS + ykiRNAi, results in further increase in the number of dying retinal neurons (or TUNEL positive cells). On the other hand, downregulation of Hippo
signaling by misexpressing hpoRNAi, wtsRNAi, yki3SA in full length wild-type FUS background in (D) GMR > FUS + hpoRNAi, (F) GMR > FUS + wtsRNAi, and (H)
GMR > FUS + yki3SA, results in significant reduction in the dying retinal neurons. (I) A graph representing the Quantitative analysis (statistics). Comparing the
number of dying nuclei of neurons, when FUS is ectopically expressed alone, and when FUS is expressed together with components of Hippo pathway in the eye,
clearly shows that downregulation of Hippo signaling significantly rescues FUS mediated neurodegeneration by blocking neuronal cell death. The p-values for the
estimation of cell death were calculated between GMR > FUS and all the components of Hippo pathway using Student's two-tailed t-test (n = 5) in Microsoft excel
software. GMR > FUS phenotype was found to be statistically significant with respect to Wild-type (****, p < .0001). The genotypes including GMR > hpo + FUS
(****, p < .0001), GMR > FUS+ hpoRNAi (****, p < .0001), GMR > FUS + wts (****, p < .0001), GMR > FUS + wtsRNAi (****, p < .0001) and (G)
GMR > FUS + yki, (****, p < .0001), GMR > FUS + ykiRNAi (*, p < .05). Note that all transgenes are in heterozygous combination. Magnification of all eye-
antennal imaginal discs is 20×.
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TUNEL positive dying cells nuclei in the wild-type eye-antennal ima-
ginal discs, which serves as control, as compared to the experiments
(Fig. 4 A, I). Targeted misexpression of FUS (GMR > FUS) exhibits an
almost two-fold increase in the number of TUNEL positive cells as
compared to the control (Fig. 4 B, I). We also tested other components
of the Hippo signaling pathway. Activation of Hippo signaling as seen in
GMR > FUS + hpo (Fig. 4C), GMR > FUS + wts (Fig. 4E),
GMR > FUS + ykiRNAi (Fig. 4G) results in the enhancement of the
neurodegenerative phenotype of GMR > FUS alone (Fig. 4I). Further-
more, activation of Hippo can result in a nearly two-fold increase in cell
death as compared to the GMR > FUS alone (Fig. 4I). Inactivation of
Hippo signaling in GMR > FUS background as seen in
GMR > FUS + hpoRNAi (Fig. 4D), GMR > FUS + wtsRNAi (Fig. 4F),
GMR > FUS + yki3SA (Fig. 4H) resulted in the suppression of
GMR > FUS mediated neurodegeneration. This suppression is accom-
panied by a significant decrease in the number of TUNEL positive cells
or dying nuclei/ cell death in differentiating eye neurons compared to
the wild-type (Fig. 4I). These observations confirm that downregulation
of Hippo signaling blocks cell death in the differentiating photoreceptor
neurons and thus plays a primary role of rescuing FUS mediated neu-
rodegeneration.
3.5. Loss of hippo signaling restores impaired axonal targeting due to FUS
expression
During Drosophila eye development, the axonal projections from
photoreceptor neurons innervates the medulla and lamina layers of the
brain's optic lobe. We used a sensory neuron marker 24B10 (Chaoptin,
DSHB), which marks the photoreceptor neurons and their axons
(Fig. 5A) (Zipursky et al., 1984). Axonal targeting studies using
Chaoptin staining is a qualitative approach to determine the function-
ality of the retinal neurons. We asked if the neurodegenerative phe-
notype seen in GMR > FUS also involves disruption of axonal targeting
from the retina to the brain. We reasoned that if the downregulation of
Hippo signaling that rescues the GMR > FUS phenotype in larval eye-
antennal disc, it also may rescue the axonal targeting from the retina to
the brain. In the wild-type eye-antennal imaginal discs, which serve as
control, R1-R6 axons of the respective photoreceptors of an ommati-
dium innervates the lamina of the brain while R7 and R8 axons in-
nervate the medulla (Meinertzhagen and Hanso, 1993; Newsome et al.,
2000). It is known that when axonal targeting is disrupted it impairs
axonal transport and leads to neurodegeneration observed in neuro-
degenerative diseases (Sarkar, 2018). We investigated the effect of
modulating hpo levels in the full-length FUS background on the axonal
projections of photoreceptor retinal axons. In comparison to the wild-
type eye-antennal imaginal disc (Fig. 5A), ectopic expression of FUS
(GMR > FUS; Fig. 5B), FUSR518K (GMR > FUSR518K; Fig. 5C) and
FUSR521C (GMR > FUSR521C; Fig. 5D) in the GMR domain resulted in
a disorganized, defective and aberrant axonal targeting. Furthermore,
gain-of-function of hpo along with FUS (GMR > FUS + hpo; Fig. 5E),
FUS R518K (GMR > FUS R518K+ hpo; Fig. 5F) and FUS R521C
(GMR > FUS R521C+ hpo; Fig. 5G) in the GMR domain severely im-
paired axonal targeting in larval eye-antennal imaginal discs as seen in
(Fig. 5B, C, D). The axonal projections significantly decrease, and fail to
innervate the lamina and medulla regions of the optic lobe (Fig. 5E, F,
G). In contrast, loss-of-function of hpo signaling by misexpressing
hpoRNAi in FUS (GMR > FUS + hpoRNAi; Fig. 5H), FUS R518K
(GMR > FUS R518K+ hpoRNAi; Fig. 5I) and FUS R521C (GMR > FUS
R521C+ hpoRNAi; Fig. 5J) background significantly restores retinal
axonal targeting in the developing eye antennal imaginal discs.
We further extended our analysis to other members of Hippo sig-
naling pathway to determine their role. Downregulation of Hippo sig-
naling by misexpressing wtsRNAi, yki3SA with FUS or mutant human FUS
(GMR > FUS + wtsRNAi, GMR > FUS R518K+ wtsRNAi, GMR > FUS
R521C + wtsRNAi, GMR > FUS + yki3SA, GMR > FUS R518K + yki3SA
and GMR > FUS R521C + yki3SA), in the GMR domain of the
developing eye also showed rescue of axonal targeting (Fig. S3). In
contrast, activation of Hippo signaling by misexpressing wts or ykiRNA
with FUS or mutant FUS (GMR > FUS + wts, GMR > FUS R518K+
wts, GMR > FUS R521C + wts, GMR > FUS + ykiRNAi,
GMR > FUSR518K + ykiRNAi and GMR > FUS R521C + ykiRNAi), in
the GMR domain of the eye showed enhanced loss of the axonal tar-
geting phenotype as compared to the controls (Fig. S3). These results
confirm that downregulation of Hippo signaling in the FUS or mutant
FUS backgrounds restores axonal targeting from the retinal neuron to
the brain.
3.6. Misexpression of FUS activates hippo signaling
A transcriptional target of Yki, death- associated inhibitor of apop-
tosis (diap1), serves as a functional read out of the Hippo signaling
pathway (Ren et al., 2010). Drosophila inhibitor of apoptosis protein 1
(Diap1), is the direct transcriptional target of the Hippo pathway. The
diap1–4.3- GFP gene, contains a Hippo response element, which drives
the Diap1 expression in response to Hippo pathway activity where GFP
is a reporter to study Hpo activity. When Hippo signaling is down-
regulated, which corresponds to the higher levels of Yki in the nuclei,
activation of diap1–4.3-GFP levels (Ren et al., 2010) is triggered. In
diap1–4.3- GFP, the GFP reporter expression is used to study Hpo ac-
tivity.
Thus, when Hippo signaling is activated, diap1–4.3-GFP levels are
decreased in the eye disc. We checked for diap1–4.3-GFP expression to
further validate if Hippo signaling is activated in GMR > FUS back-
ground. The wild-type expression of diap1–4.3-GFP (tagged with a GFP
reporter) is mostly restricted to the photoreceptor neurons present to-
wards the posterior end of eye discs, and in the antennal region of eye-
antennal imaginal disc (Fig. 6A, A'), as well as serves as the control. The
GMR domain extends from the posterior margin of the eye disc to the
Morphogenetic furrow (MF) which is marked by a proneural marker,
ELAV (Fig. 6A, A', white arrowheads). Increasing the levels of FUS
(GMR > FUS + diap1–4.3-GFP, Fig. 6B, B'), FUS R518K (GMR > FUS
R518K + diap1–4.3-GFP, Fig. 6C, C') and FUS R521C (GMR > FUS
R521C + diap1–4.3-GFP; Fig. 6D, D') in the GMR domain resulted in
significant reduction of Diap1 levels (Fig. 6E). These results confirm
that an increase in levels of FUS protein does not affect the expression
of downstream targets of Hippo signaling.
To determine if Hippo signaling is activated in mammalian cells, we
checked the levels of LATS1 and phosphorylated LATS1, one of the
components of Hippo signaling cascade, in HEK293T cells ectopically
expressing either FUS-WT or ALS-associated mutants, FUS-R518K and
FUS-R521C. We observed that while the total levels of LATS1 protein
were unchanged between the groups (Fig. 6F,F"), the levels of phos-
phorylated LATS1 were increased in the mutant FUS-expressing cells
when compared to the untransfected control (Fig. 6F,F'), suggesting a
hyper-activation of upstream kinase cascade. Ectopic expression of FUS-
WT alone did not change the phosphorylated LATS1 levels (Fig. 6F, F'),
indicating that activation of Hippo signaling was specific to mutant
FUS.
3.7. Modulating levels of JNK signaling pathway modulates FUS mediated
neurodegeneration
It is known that Hippo regulates JNK signaling (Ma et al., 2015; Ma
et al., 2017), which is involved in neurodegeneration and cell death
(Herdegen et al., 1997; Sarkar et al., 2016; Tare et al., 2011). We tested
if modulating JNK signaling levels can block FUS-mediated neurode-
generation. JNK signaling comprises of a series of kinases, which in turn
regulates expression of puckered (puc) (Fig. 7A). puc, a dual phospha-
tase, regulates JNK signaling through a negative feedback loop (Martin-
Blanco et al., 1998). The phospho-Jun kinase enzyme can phosphor-
ylate its downstream substrate Jun in its N- terminal domain. The
phosphorylated Jun is used to quantify levels of JNK activation using an
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antibody against p-Jun (Tare et al., 2011). Initially we tested JNK ac-
tivation levels by quantifying the JNK levels with quantitative-PCR
(qPCR) (Fig. 7B) and then quantifying levels of the p-JNK protein in
semi-quantitative western blot (Fig. 7C, C'). In GMR > FUS back-
ground, JNK gene expression levels increased two fold, whereas in
other constructs like GMR > FUS R518K or GMR > FUS R521C, the
JNK expression levels were 10 and 4 folds respectively (Fig. 7B). We
also employed a semi-quantitative approach to compare the amount of
phospho-Jun kinase (p-JNK) levels in the wild type to that of FUS
(GMR > FUS) and mutant FUS (GMR > FUS R518K and GMR > FUS
R521C). In comparison to the wild type, p-JNK levels were upregulated
in GMR > FUS, GMR > FUS R518K and GMR > FUS R521C back-
grounds. Tubulin bands served as a control in the western blot. We
calculated the intensity of the bands and presented them as a graph
(Fig. 7C, C').
To further test if FUS mediated neurodegeneration can be sup-
pressed by modulating the levels of JNK signaling, we initially activated
JNK signaling by misexpressing Djunaspv7 and constitutively active
hemipterous (hepAct) in FUS and mutant FUS (FUS R518K and FUS
R521C) backgrounds. In comparison to the wild-type eye imaginal disc
and the adult eye (Fig. 7D, D'), we analyzed their resultant phenotypes
in both eye-antennal imaginal discs (Fig. 7 F, G, H, J, K, L) and the adult
fly eyes (Fig. 7 F', G', H' J',K',L'). Targeted misexpression of D-jun and
hep alone in the GMR domain (GMR > jun and GMR > hep), which
served as control, led to a strong neurodegenerative phenotype in eye-
antennal imaginal discs (Fig. 7E, I), adult fly eyes (Fig. 7 E', I'). More-
over, activation of the JNK signaling by misexpressing hepAct along with
FUS or mutant FUS in the GMR domain worsens the neurodegeneration
phenotype (Fig. 7J-L') as seen in eye imaginal discs (Fig. 7D) and adult
fly eyes (Fig. 7D'). Similarly, misexpression of Djunaspv7 with FUS or
mutant FUS in the GMR domain (GMR > FUS + Djunaspv7, GMR > FUS
R518K + Djunaspv7 and GMR > FUS R521C + Djunaspv7), resulted in a
small, rough eye phenotype with loss of pigment cells (Fig. 7F-H'). We
further validated our results by downregulating the JNK signaling in
FUS gain-of-function backgrounds. Misexpression of bskDN
(GMR > bskDN) or puc (GMR > puc) alone, which serve as controls,
exhibits near wild-type eye imaginal discs (Fig. 7M,Q) and adult fly
eyes (Fig. 7 M'Q'). Downregulating JNK by misexpressing bskDN with
FUS in GMR domain (GMR > FUS + bskDN) or FUS R518K
(GMR > FUS R518K + bskDN), GMR > FUS R521C (GMR > FUS
Fig. 5. Loss of function of Hpo restores axonal pro-
jections (impaired by gain of function of FUS) from
retina to the brain.
MAb24B10 (Chaoptin), marks the retinal axons that
innervate lamina and medulla regions of the brain.
Top panel shows, (A) wild-type larval eye-antennal
imaginal disc, and (B) GMR > FUS (C) GMR > FUS
R518K, and (D) GMR > FUS R521C showing ex-
pression of the retinal axons marked by 24B10 in
control and when FUS or mutant FUS (FUS R518K
and FUS R521C) are misexpressed in the GMR do-
main respectively. Activation of Hippo signaling by
misexpressing hpo, along with FUS or mutant FUS
results in impaired targeting of retinal axons to the
brain (E) GMR > FUS + hpo, (F) GMR > FUS
R518K + hpo, (G) GMR > FUS R521C + hpo, as
compared to the wild-type (A). In-activation of
Hippo signaling by misexpressing hpoRNAi, along
with FUS and mutant FUS results in restoration of
targeting of retinal axons to the brain (H)
GMR > FUS + hpoRNAi, (I) GMR > FUS
R518K + hpoRNAi, (J) GMR > FUS
R521C + hpoRNAi. Note that all transgenes are in
heterozygous combination. Magnification of all the
eye-antennal imaginal discs is 20X.
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R521C + bskDN), exhibits a strong rescue of the FUS mediated neuro-
degenerative phenotype (Fig. 7N-P'). Similarly, when puc was mis-
expressed with FUS or mutant FUS (GMR > FUS + puc) or FUS R518K
(GMR > FUS R518K + puc), GMR > FUS R521C (GMR > FUS
R521C + puc) as seen in the eye imaginal discs (Fig. 7 R, S, T) and adult
fly eyes (Fig. 7 R', S', T'). Thus, activation of JNK signaling is responsible
in FUS mediated neurodegeneration.
4. Discussion
ALS, a progressive neurodegenerative disorder, is caused by mis-
localization of FUS in cytoplasm which impairs the RNA metabolism
(Lanson et al., 2011). However, the molecular genetic basis of this
disease is elusive. It is possible that mislocalization of FUS proteins
trigger(s) aberrant signaling, which results in the onset of the pro-
gressive neurodegenerative phenotype. Therefore, there is a need to
identify the downstream targets of signaling pathways activated by the
FUS mislocalization. Generation of animal model systems like
Drosophila, which are genetically tractable, have facilitated the use of
genetic screens to identify the modifiers of neurodegenerative pheno-
types (Casci and Pandey, 2015; Pandey and Nichols, 2011; Sarkar et al.,
2016).
Targeted misexpression of FUS and its mutants in the differentiating
retinal neurons using transgenic approaches exhibited strong neuro-
degenerative phenotypes in the Drosophila adult eye (Daigle et al.,
2013; Lanson Jr et al., 2011). In a forward genetic screen using the
molecularly defined deficiencies, we identified a deficiency line Df(2R)
BSC782, which can rescue FUS mediated neurodegeneration. This de-
ficiency uncovers hpo and other genes (Fig. 1). In a candidate gene
approach, where we tested individual genes uncovered by the defi-
ciency Df(2R)BSC782, we identified hpo as one of the genetic modifiers
of ALS phenotypes (Fig. 2). Interestingly, it has been shown that FUS/
LATS1/2 inhibits hepatocellular carcinoma (HCC) via activating Hippo
pathway (Bao et al., 2018). Gain-of-function of hpo results in cell death
whereas hpo loss-of-function results in over proliferation and over-
growth (Kango-Singh and Singh, 2009; Udan et al., 2003). We found
that modulating the levels of hpo can modify FUS mediated neurode-
generation phenotype. Loss-of-function of hpo can significantly rescue
the neurodegenerative phenotype of FUS (GMR > FUS) and other
mutant (GMR > FUS R518K and GMR > FUS R521C) accumulation
(Fig. 2). We further confirmed that the Hippo pathway is activated in
FUS overexpressing retinal neurons (GMR > FUS) to trigger neurode-
generation in the Drosophila eye (Fig. 3).
4.1. Role of Hippo in neurodegeneration
Studies from ours and other labs have shown that other components
of Hippo pathway like Fat (Ft), Teashirt (Tsh), and Crumbs (Crb) induce
neurodegeneration in models of Alzheimer's Disease (Moran et al.,
2013; Napoletano et al., 2011; Sarkar et al., 2016; Steffensmeier et al.,
2013). In addition, the Hippo pathway may also be involved in neural
development (Jiang et al., 2009; Wittkorn et al., 2015). The major
function of the Hippo signaling pathway has been in growth regulation
and cancer (Kango-Singh and Singh, 2009; Ma et al., 2019; Snigdha
et al., 2019). Recently, Hippo signaling has been implicated in many
disease models where it plays role in apoptosis, autophagy, regenera-
tion and cell survival (Calamita and Fanto, 2011; Ma et al., 2019). Thus,
it is interesting to find a role for Hippo pathway in FUS mediated
neurodegeneration.
Our genetic analysis suggested that Hippo signaling acts down-
stream of FUS accumulation (Fig. S2). In genetic backgrounds where
FUS and its mutant proteins were misexpressed in the eye, we found a
robust accumulation of FUS protein in the eye imaginal disc. In
GMR > FUS, Df(2R)BSC782/+ background, FUS accumulation was
unaltered suggesting that the rescue of the neurodegeneration pheno-
type occurred by a mechanism downstream of FUS accumulation
(Fig.S1). Our data shows that FUS accumulation triggers downstream
signaling events involving Hippo and JNK signaling. We tested the le-
vels of diap1–4.3-GFP, which serves as a reporter for Hippo signaling, in
GMR > FUS and GMR > FUS R518K and GMR > FUS R521C back-
ground. When Hippo signaling is activated it triggers cell death and
diap1–4.3-GFP levels are downregulated (Zhang et al., 2008). We found
that diap1–4.3-GFP levels were downregulated in these backgrounds,
which suggests that Hippo signaling is activated (Fig. 6). Earlier studies
have shown that Hippo can regulate JNK signaling (Ma et al., 2015; Ma
et al., 2017). We also tested the reporters of JNK signaling and found
that JNK signaling is activated in gain-of-function of FUS (Fig. 7).
Furthermore, if we block these signaling pathways, even though the
neurodegenerative phenotype caused by accumulation of FUS is res-
cued, it does not affect the accumulation of FUS protein suggesting that
JNK signaling doesn't block expression or turnover of toxic FUS protein.
Interestingly, JNK signaling is dependent on timing (temporal scale).
We have assayed the effect of JNK signaling in the matrure third instar
eye-imaginal disc. Based on our results, we propose a model that ac-
cumulation of FUS triggers Hippo and JNK signaling, which acts
downstream of FUS accumulation. Activation of Hippo signaling and
JNK signaling triggers neurodegeneration (Fig. 8).
Fig. 6. Targeted misexpression of FUS in the developing eye of Drosophila, transcriptionally activates Hippo signaling. diap1–4.3-GFP (diap1, tagged with GFP
reporter) shows the transcriptional activity of Hippo signaling pathway. Gain-of-function of hpo triggers cell death and result in downregulation of diap1–4.3-GFP
levels. Panels shows diap1–4.3-GFP (green) and Elav (red) expression in the eye-antennal imaginal discs from larvae of all the genotypes. (A, A') Wild-type expression
of diap1–4.3-GFP in eye-antennal imaginal discs, which serve as control. The white arrowheads marks the boundary of domain of GMR expression domain on dorsal
and ventral margins of the eye disc. Misexpression of FUS or mutant FUS (R518K and FUS R521C) along with diap1–4.3-GFP in the GMR domain of eye (B, B')
GMR > FUS+ diap1–4.3-GFP, (C, C') GMR > FUS R518K+ diap1–4.3-GFP, (D, D') GMR > FUS R521C+ diap1–4.3-GFP, exhibits downregulation of diap1–4.3-GFP
reporter. (E) Quantitative analysis, comparing the GFP intensity levels in the eye imaginal disc of (A) diap-1-4.3GFP, which serve as control, (B) GMR > FUS, (C)
GMR > FUS R518K, and (D) GMR > FUSR521C. The quantification of GFP intensity was done using in built program in Olympus Fluoview laser scanning confocal
microscope. The p- values for the estimation of diap1 4.3-GFP intensity levels were calculated from five individual eye-imaginal disc for each genotype using a
Student's t-test in MS excel and a graph was plotted. (A, A', B', C', D') The diap1 4.3-GFP signal intensity was calculated only in the GMR domain, which extends from
the posterior margin of the eye imaginal disc to the MF which is marked by white arrowheads. The data exhibits that GFP levels are reduced in the backgrounds
where FUS targeted expression occurs. Genotypes including, GMR > FUS+ diap1–4.3-GFP (***, p < .001), GMR > FUS R518K+ diap1–4.3-GFP (**, p < .01) and
GMR > FUS R521C+ diap1–4.3-GFP (***, p < .001) were found to be statistically significant from diap1–4.3-GFP (control). GMR > FUS+ diap1–4.3-GFP was found
to be statistically significant from GMR > FUS R518K+ diap1–4.3-GFP (***, p < .001) while non-significant from GMR > FUS R521C+ diap1–4.3-GFP (N.S.,
p > .05). GMR > FUS R518K+ diap1–4.3-GFP was found to be statistically significant as compared to GMR > FUS R521C+ diap1–4.3-GFP (**, P < .01). Note that
all transgenes are in heterozygous combination. The magnification of all the eye-antennal imaginal discs is 20×. (F, F', F″) Semi-quantitative western blot (the
tubulin bands in western blot, serve as controls) and (F', F″) quantitative analysis of western blot represented in the form of a graph (provides the levels of (F') p-
LATS1 and (F″) LATS1 levels in untransfected HEK293T cells (ATCC® CRL-3216™) (negative control), HEK293T cells (ATCC® CRL-3216™) cells transfected with WT
FUS, mutant FUS (FUS R518K and FUS R521C). The intensity of the (F') p-LATS1, and (F″) LATS1 bands was quantified, normalized by image studio (Li-COR
Biosciences), and the graph was made using Graphpad Prism. The p-values for the estimation of p-JNK levels in all combinations in Western Blot were calculated in a
set of three (n = 3), using one-way ANOVA with Tukey's multiple comparisons test. The p-values for untransfected versus FUS R518K = 0.0015 and p-value for
untransfected versus R521C = 0.0011. Errors bar indicate s.e.m. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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Thus, we demonstrate that inactivation of Hippo and JNK signaling
can rescue FUS-mediated neurodegeneration in Drosophila eye. Our
data suggests that this neuropathy can be alleviated by modulating
levels of Hippo signaling and JNK signaling pathways (Figs. 2, 3, 7).
Both pathways are crucial for normal development and in disease
backgrounds for onset and progression. The members of these two
pathways seem to be interesting therapeutic targets, which can mitigate
the onset or rapid progression of neurodegenerative diseases like ALS.
MST, the mammalian homolog of hpo, a kinase, is involved in many
biological processes from cell proliferation to cell death, patterning and
growth (Kango-Singh and Singh, 2009; Yu and Guan, 2013). There are
two hpo homologues MST1 and MST2 in the mammalian genome
(Creasy and Chernoff, 1995). In addition, hpo is involved in other
neurodegenerative models like the superoxide dismutase SOD1 G93A
mouse model of ALS (Lee et al., 2013), and in VAPB models in Droso-
phila (Sanhueza et al., 2015). The SOD1 G93A mouse model of ALS is
linked to decrease in motor neuron survival. It has been shown that
downregulation of MST1, fly homolog of hpo, exhibits neuroprotective
Fig. 7. Modulating the levels of JNK signaling affects FUS mediated neurodegeneration. Panel shows, (A) Schematic representation of JNK signaling pathway, (B)
levels of phospho-JNK (p-JNK) in quantitative-PCR (q-PCR), (C) semi-quantitative western blot (the tubulin bands in western blot, serve as controls) and (C')
quantitative analysis of western blot represented in the form of a graph (provides the levels of JNK in WT FUS and mutant FUS (FUS R518K and FUS R521C)
background. (C') The p-JNK bands intensity was quantified, normalized and the graph was made using Image J software (NIH). The p-values for the estimation of p-
JNK levels in all combinations in Western Blot were calculated in a set of three (n = 3), using Student's t-test in MS Excel software. GMR > FUS was found to be
statistically significant from 1. Wild-type (p < .05, *), 2. GMR > FUS R518K (p < .0001, ****), and 3. GMR > FUS-R521C (P < .001, ***). Genotypes including
GMR > FUS, GMR > FUS-R518K were found to be statistically different (p < .05, *) and (p < .001, ***) respectively, while GMR > FUS-R512C was found to be
non-significant (p > .05, N.S.) as compared to Wild-type (Canton-S, Control). (B, C, C') When compared to wild-type controls, higher levels of p-JNK were observed
when FUS or mutant FUS are misexpressed in GMR domain of the eye (GMR > FUS, GMR > FUS R518K and GMR > FUS R521C) in q-PCR and western blot
approaches. (D) Wild-type eye-antennal imaginal disc and (D') adult fly eye, serve as the control. Note the expression of Wg (green) and Elav (red) in the eye-antennal
imaginal discs from third instar larvae of all the genotypes. Activation of JNK signaling by misexpressing activated hemipterous (hep; GMR > hepAct), and activated
Djun (GMR > junaspv7) alone in GMR domain of the eye, results in few number of dying cells in (I,E) eye imaginal discs and (I',E') adult fly eye, respectively.
Furthermore, activation of JNK signaling by misexpressing hep and jun in FUS or mutant FUS background using GMR-Gal4 driver, (J,J') GMR > FUS + hepAct, (K,K')
GMR > FUS R518K + hepAct and (L,L') GMR > FUS R521C + hepAct, (F,F') GMR > FUS + junaspv7, (G,G') GMR > FUS R518K + junaspv7 and (H,H') GMR > FUS
R521C + junaspv7, results in (J,K,L,F,G,H) dramatic increase in dying cell population in the eye-antennal imaginal discs, leading to (J',K',L',F',G',H') no-eye or small eye
with loss of pigmentation phenotype in the adult fly eyes. However, downregulation of JNK signaling by misexpression of dominant negative bsk, and puc (a dual
phosphatase) alone in GMR domain (GMR > bskDN and GMR > puc), results in near wild-type (M,Q) eye-antennal imaginal discs and (M',Q') adult fly eyes
respectively. However, downregulating JNK signaling by misexpressing bsk, and puc in FUS or mutant FUS background (N,N') GMR > FUS + bskDN, (O,O′)
GMR > FUS R518K + bskDN, (P,P') GMR > FUS R521C + bskDN and (R,R') GMR > FUS + puc, (S,S') GMR > FUS R518K + puc and (T,T') GMR > FUS
R521C + puc, results in significant reduction in the dying cell population in (N,O,P,R,S,T) eye imaginal discs, thereby leading to a strong rescue of the
(N',O′,P′,R',S′,T') adult fly eye phenotype. The magnification of all eye-antennal imaginal disc is 20×. (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
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function in this mouse ALS model (Lee et al., 2013). Hippo signaling
dysregulation has been identified in Huntington's disease brain and
neuronal stem cells (Mueller et al., 2018). Thus, MST1/ Hippo can be an
interesting link between cancer and neurodegenerative disorder like
ALS (Yamamoto et al., 2019). The members of Hippo pathway can serve
as potential therapeutic target for ALS as well as other neurodegen-
erative disorder.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nbd.2020.104837.
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